Literature DB >> 31578609

[Heart failure in old age : Current recommendations in view of the revised national treatment guidelines on chronic heart failure].

Anne Lambrecht1, Roland Hardt2.   

Abstract

Clinical symptoms of heart failure in older patients can be similar to those of other diseases in geriatrics. Therefore, the diagnosis should be confirmed by echocardiography. The treatment of older patients with heart failure with reduced left ventricular ejection fraction (HFrEF) should be carried out in accordance with the guidelines with regular control of volume status, renal function and serum electrolytes. Due to the lack of effective treatment of heart failure with preserved ejection faction (HFpEF) blood pressure control as a measure of prevention is important. Patients can benefit from the new treatment options for secondary mitral regurgitation if the patient selection is correct. For older and frail patients a special management would be desirable, with the aim of reducing functional loss through hospitalization. In order to reduce the rehospitalization rate of older patients, it is necessary to improve the collaboration between outpatient and inpatient care providers and nursing personnel should be better qualified.

Entities:  

Keywords:  Angiotensin receptor neprilysin inhibitor; Frailty syndrome; Heart failure with preserved ejection fraction; Mineralocorticoid receptor antagonist; Mitral regurgitation

Mesh:

Substances:

Year:  2019        PMID: 31578609     DOI: 10.1007/s00391-019-01617-0

Source DB:  PubMed          Journal:  Z Gerontol Geriatr        ISSN: 0948-6704            Impact factor:   1.281


  20 in total

1.  Efficacy and safety of ivabradine in chronic heart failure across the age spectrum: insights from the SHIFT study.

Authors:  Luigi Tavazzi; Karl Swedberg; Michel Komajda; Michael Böhm; Jeffrey S Borer; Mitja Lainscak; Ian Ford
Journal:  Eur J Heart Fail       Date:  2013-06-26       Impact factor: 15.534

2.  Dose response characterization of the association of serum digoxin concentration with mortality outcomes in the Digitalis Investigation Group trial.

Authors:  Kirkwood F Adams; Javed Butler; J Herbert Patterson; Wendy Gattis Stough; Jerry L Bauman; Dirk J van Veldhuisen; Todd A Schwartz; Hani Sabbah; John I Mackowiak; Hector O Ventura; Jalal K Ghali
Journal:  Eur J Heart Fail       Date:  2016-08       Impact factor: 15.534

3.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

Authors:  Salim Yusuf; Bertram Pitt; Clarence E Davis; William B Hood; Jay N Cohn
Journal:  N Engl J Med       Date:  1991-08-01       Impact factor: 91.245

4.  Clinical evaluation of geriatric outpatients with suspected heart failure: value of symptoms, signs, and additional tests.

Authors:  Irène Oudejans; Arend Mosterd; Johanna A Bloemen; Mark J Valk; Edwin van Velzen; Jos P Wielders; Nicolaas P Zuithoff; Frans H Rutten; Arno W Hoes
Journal:  Eur J Heart Fail       Date:  2011-03-19       Impact factor: 15.534

5.  Incidence, prevalence and 1-year all-cause mortality of heart failure in Germany: a study based on electronic healthcare data of more than six million persons.

Authors:  Christoph Ohlmeier; Rafael Mikolajczyk; Johann Frick; Franziska Prütz; Wilhelm Haverkamp; Edeltraut Garbe
Journal:  Clin Res Cardiol       Date:  2015-03-17       Impact factor: 5.460

6.  Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).

Authors:  Marcus D Flather; Marcelo C Shibata; Andrew J S Coats; Dirk J Van Veldhuisen; Aleksandr Parkhomenko; Joszef Borbola; Alain Cohen-Solal; Dan Dumitrascu; Roberto Ferrari; Philippe Lechat; Jordi Soler-Soler; Luigi Tavazzi; Lenka Spinarova; Jiri Toman; Michael Böhm; Stefan D Anker; Simon G Thompson; Philip A Poole-Wilson
Journal:  Eur Heart J       Date:  2005-01-09       Impact factor: 29.983

7.  Transcatheter Mitral-Valve Repair in Patients with Heart Failure.

Authors:  Gregg W Stone; JoAnn Lindenfeld; William T Abraham; Saibal Kar; D Scott Lim; Jacob M Mishell; Brian Whisenant; Paul A Grayburn; Michael Rinaldi; Samir R Kapadia; Vivek Rajagopal; Ian J Sarembock; Andreas Brieke; Steven O Marx; David J Cohen; Neil J Weissman; Michael J Mack
Journal:  N Engl J Med       Date:  2018-09-23       Impact factor: 91.245

8.  Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

Authors: 
Journal:  N Engl J Med       Date:  1987-06-04       Impact factor: 91.245

9.  Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study.

Authors:  Milton Packer; Michael B Fowler; Ellen B Roecker; Andrew J S Coats; Hugo A Katus; Henry Krum; Paul Mohacsi; Jean L Rouleau; Michal Tendera; Christoph Staiger; Terry L Holcslaw; Ildiko Amann-Zalan; David L DeMets
Journal:  Circulation       Date:  2002-10-22       Impact factor: 29.690

10.  Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HF.

Authors:  Pardeep S Jhund; Michael Fu; Edmundo Bayram; Chen-Huan Chen; Marta Negrusz-Kawecka; Arvo Rosenthal; Akshay S Desai; Martin P Lefkowitz; Adel R Rizkala; Jean L Rouleau; Victor C Shi; Scott D Solomon; Karl Swedberg; Michael R Zile; John J V McMurray; Milton Packer
Journal:  Eur Heart J       Date:  2015-07-31       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.